Your browser doesn't support javascript.
loading
Changes in Cardiovascular Biomarkers Associated With the Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes.
Lawler, Patrick R; Liu, Hongyan; Frankfurter, Claudia; Lovblom, Leif Erik; Lytvyn, Yuliya; Burger, Dylan; Burns, Kevin D; Brinc, Davor; Cherney, David Z I.
Afiliação
  • Lawler PR; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
  • Liu H; Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Ontario, Canada.
  • Frankfurter C; Heart & Stroke/Richard Lewar Centres of Excellence in Cardiovascular Research, University of Toronto, Toronto, Ontario, Canada.
  • Lovblom LE; Division of Nephrology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada hongyan.liu@uhn.ca.
  • Lytvyn Y; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Burger D; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Burns KD; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Brinc D; Division of Nephrology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Cherney DZI; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Diabetes Care ; 44(3): e45-e47, 2021 03.
Article em En | MEDLINE | ID: mdl-33436398
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá